.

Echolight announces the opening of a new corporate office in the United States. A steady growth over the years has favored the expansion of the innovative Italian company in many countries of the world, thanks to the numerous certifications obtained for the marketing of its products, with the support of a solid network of partners specialized in the sale of medical devic...

New important recognition for Echolight: REMS technology (Radiofrequency Echographic Multi Spectrometry), the first ultrasound-based method to diagnose the osteoporosis and assess the risk of fragility fractures, is officially included in the Inter-Company Ministerial Guidelines for the correct identification and management of fragility fractures (Download Guidelines), p...

“Radiofrequency Echographic Multi‑Spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting” was elected “Paper Of The Month” by ESCEO for January 23 REMS lands in nephrology: the international journal Aging Clinical and Experimental Research (ACER) publishes the paper “Radiofrequency echographic multi-spectrometry and DXA for the ...